Drug Database
SU

sumatriptan succinate (Imigran Nasal Spray / Imitrex Nasal Spray / Suminant)

✓ Approved

GSK · HTR1D · 小分子

什么是 sumatriptan succinate?

sumatriptan succinate 是一种小分子,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Inhaled。

药物档案

商品名Imigran Nasal Spray, Imitrex Nasal Spray, Suminant
公司GSK
药物类别小分子
分子靶点HTR1D
给药途径Inhaled
状态Approved

作用机制

分子靶点

sumatriptan succinate 作用于 1 个分子靶点:

HTR1D5-hydroxytryptamine receptor 1D (HTR1DA, HT1DA)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

sumatriptan succinate 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersMigraine✓ Approved
Nervous system disordersCluster headache✓ Approved

相关研究文献

PubMedThe FEBS journal2026-08-05

Common pathways and outliers in glucose catabolism across Trypanosomatidae.

Opperdoes Fred R FR, Alencar Mayke B MB, Silber Ariel M AM, Škodová-Sveráková Ingrid I et al.

Glucose catabolism in trypanosomatids differs significantly from that in most other eukaryotes. Here, the first few enzymes of the pathway are all located inside glycosomes, that is, the peroxisome-like microbodies uniquely present in the Kinetoplastida and Diplonemida of the Euglenozoa. Glycosomal AMP/ADP/ATP and NAD(H)+ pools cannot freely equilibrate with their corresponding cytosolic pools, and any ATP and NAD+ consumed within the organelles have to be regenerated inside to maintain the redox balance and glycolytic flux. Analyses of the reported end-products of both aerobic and anaerobic glucose catabolism experiments in various trypanosomatids have revealed that the ability to maintain the intra-glycosomal ATP/ADP energy balance and NAD+/NADH redox balance is essentially limited to three pathways. 1) Under aerobic conditions, glycosomal NADH is preferably reoxidized indirectly by molecular oxygen via a dihydroxyacetone phosphate/glycerol-3-phosphate shuttle which links to the mitochondrial respiratory chain, where either an alternative oxidase or a cytochrome oxidase functions as terminal oxidases. 2) Under oxygen starvation or limited activity of enzymes of the DHAP/G3P shuttle, glycosomal NADH is reoxidized by a redirection of part of the cytosolic PEP towards the glycosome, where it is reduced to succinate. 3) A succinate/fumarate/malate cycle permits an exchange of succinate and malate between the glycosome/cytosol and the mitochondrion via a mitochondrial dicarboxylate carrier, whereby succinate is oxidized to fumarate by the mitochondrial succinate dehydrogenase (complex II). In parallel, trypanosomatids have evolved various pathways to form sufficient ATP to satisfy their energy requirements. Some trypanosomatids survive true anaerobiosis through pyruvate dismutation or fermentation of propionic acid.

PMID 42552839
阅读全文 →
PubMedPest management science2026-08-05

Design, synthesis, and antifungal activity study of N-substituted phenyl pyrazole containing amides.

Zhang Wei W, Yu Renwu R, Wang Yi Y, Xing Shisen S et al.

Plant pathogenic fungi pose a serious threat to global crop productivity. Succinate dehydrogenase inhibitors (SDHIs) exhibit superior curative activity, longer residual efficacy, and lower mammalian toxicity compared to other fungicides, making them the most studied fungicide class. A series of N-substituted phenyl pyrazole amide derivatives (D1-D32) were designed by nitrogen substitution and amide linker extension to enhance their antifungal activity and broad-spectrum properties. As a result, the crystal structures of compounds D6 and D19 were researched, and compound D19 showed strong activity against Rhizoctonia cerealis (half-maximal effective concentration (EC50) = 4.40 μg mL-1), with protective and curative effects of 83.0% and 72.8% at 100 μg mL-1, respectively. Mechanistic studies revealed that compound D19 could inhibit the activity of succinate dehydrogenase (SDH), disrupting the tricarboxylic acid (TCA) cycle. Molecular docking and molecular dynamics simulations confirmed the binding mode of compound D19 with SDH, and toxicity assays revealed a favorable safety profile of compound D19. Novel N-substituted phenyl pyrazole amide derivatives with strong antifungal activity and safety profile can be used as a lead compound for the new type of SDHI fungicide. © 2026 Society of Chemical Industry.

PMID 42552637
阅读全文 →
PubMedArchive of clinical cases2026-08-05

Extranodal NK/T-cell lymphoma, nasal type, presenting as a necrotic palatal ulcer.

Zarei Mahdiyeh M, Tonkaboni Arghavan A, Sabouri Parastoo P

Extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, is an aggressive Epstein-Barr virus (EBV)-associated lymphoma that predominantly involves the nasal cavity and upper aerodigestive tract. Primary oral manifestations are rare and may clinically mimic benign inflammatory or infectious conditions, resulting in delayed diagnosis. This report presents a rare case of ENKTL initially manifesting as a rapidly progressive necrotizing palatal ulcer. A 44-year-old man presented with a three-week history of a necrotic ulcer on the posterior hard palate. Imaging revealed extensive midfacial destruction, including palatal perforation, nasal septal erosion, turbinate destruction, ethmoidal involvement, and medial orbital wall extension. Histopathologic examination demonstrated atypical large lymphoid cells with extensive necrosis and infiltration into adipose and muscle tissue. Immunohistochemical staining demonstrated diffuse expression of LCA and CD3, focal expression of CD30, absence of CD20, ALK, and CD56 expression, and a high proliferative activity, as evidenced by a Ki-67 index of approximately 90%. Based on the histomorphologic and immunophenotypic features, extranodal NK/T-cell lymphoma was suspected. Chromogenic in situ hybridization (CISH) for Epstein-Barr virus-encoded RNA (EBER) demonstrated strong nuclear positivity in atypical lymphoid cells, confirming the diagnosis of ENKTL, nasal type. The patient achieved complete remission after chemotherapy; however, eight months later, the patient developed a systemic relapse that was diagnosed as peripheral T-cell lymphoma. This case highlights the diagnostic complexity of ENKTL presenting as a destructive palatal lesion. Comprehensive histopathologic evaluation, detailed immunophenotyping, and EBV confirmation by EBER are essential for accurate diagnosis and timely oncologic management. ENKTL should be considered in the differential diagnosis of rapidly progressive oral necrotic lesions unresponsive to conventional therapy.

PMID 42553625
阅读全文 →
PubMedPest management science2026-08-05

Molecular and transcriptomic insights into differential sensitivity of Rhizoctonia anastomosis groups to the SDHI fungicide thifluzamide.

Wang Yan Y, Wang Mengyu M, Su Jing J, Wei Songhong S

Sensitivity to succinate dehydrogenase inhibitor (SDHI) fungicides varies considerably among Rhizoctonia anastomosis groups, yet the molecular basis of this variation remains poorly understood. In this study, the mechanisms underlying the contrasting responses of multinucleate Rhizoctonia solani AG1-IA and binucleate Rhizoctonia AG-Bb to the SDHI fungicide thifluzamide were investigated through an integrated analysis combining fungicide sensitivity assays, structural modeling, molecular docking, molecular dynamics simulations, enzymatic activity measurements and transcriptome profiling. Baseline sensitivity tests revealed a pronounced difference between the two groups. The mean median effective concentration (EC50) value of AG-Bb isolates (1.99 mg L-1) was nearly 28.4-fold higher than that of AG1-IA (0.07 mg L-1), indicating markedly lower sensitivity in the binucleate strain. Structural modeling showed that thifluzamide binds to the ubiquinone-binding pocket formed by SDHB, SDHC and SDHD of the succinate dehydrogenase (SDH) complex. Molecular dynamics simulations further demonstrated a stronger and more stable interaction in AG1-IA, reflected by a substantially lower binding free energy (-36.12 kcal mol-1) compared with AG-Bb (-25.76 kcal mol-1). Consistently, thifluzamide elicited substantially stronger suppression of SDH enzymatic activity in AG1-IA than in AG-Bb. Transcriptomic analysis revealed that genes involved in the ABC transporter pathway were specifically enriched in AG-Bb, suggesting enhanced efflux capacity. These findings provide mechanistic insight into intrinsic SDHI sensitivity differences among Rhizoctonia groups and contribute to resistance risk assessment for SDHI fungicides. © 2026 Society of Chemical Industry.

PMID 42552690
阅读全文 →
PubMedLaryngoscope investigative otolaryngology2026-08-05

Impact of Topical Steroid Nasal Irrigation Adherence on Chronic Rhinosinusitis and Allergic Rhinitis Patient Outcomes.

He Clifford Jiajun CJ, Baker Omer O, LaMonte Olivia O, Verpukhovskiy Philipp P et al.

High volume steroid nasal rinses are often prescribed for chronic rhinosinusitis and allergic rhinitis. Although the general importance of medication adherence is well established, the specific relationship between objectively measured adherence to topical steroid irrigation and patient-reported clinical outcomes has not been previously demonstrated. This study aims to investigate the effect of topical steroid nasal rinse adherence on patient outcomes. This prospective longitudinal study recruited 97 patients with chronic rhinosinusitis or allergic rhinitis. All patients were prescribed twice-daily high-volume budesonide isotonic saline sinus rinses. Objective adherence data through quantified medication usage were collected over 8 weeks. Patient outcomes were assessed via the 22-item Sino-Nasal Outcome Test (SNOT-22), a sinus discomfort visual analog scale (VAS, 0-100), and patient-perceived surgery need. Generalized estimating equations were used to analyze the impact of adherence on symptom outcomes. Higher adherence was significantly associated with improvement in both VAS (β = -0.18, p < 0.001) and SNOT-22 (β = -0.10, p = 0.024) but was not associated with increased surgery desire. Median adherence was overall 47.5%, higher in patients with recent sinus surgery (< 3 months: 55.6%) and higher baseline symptom severity (SNOT-22 ≥ 20: 51.6%), with correspondingly larger improvements in clinical outcomes. Objective adherence to budesonide sinus irrigation significantly associates with improved patient-reported outcomes, with the strongest benefit seen in patients with higher baseline symptoms and in the early postoperative period. Targeting adherence interventions may yield clinically meaningful improvements in sinonasal quality of life. 2.

PMID 42553421
阅读全文 →
PubMedSaudi journal of anaesthesia2026-08-05

A comparative study to assess the efficacy of atomized versus drops administration of intranasal midazolam as premedication in pediatric patients undergoing elective surgery under general anesthesia-A prospective randomized double-blind study.

Mandaknalli Parag P, Sholapur Imran I, Kori Rachana Shivanand RS

Preoperative anxiety is one of the major challenges in perioperative care of pediatric surgical patients. Intranasal midazolam is a preferred route of drug administration owing to its ease of administration, non-invasive delivery, and rapid absorption through the highly vascular nasal mucosa, but the method of administration affects the efficacy. To compare the efficacy of atomized versus drop administration of intranasal midazolam (0.3 mg/kg) as a premedication in pediatric patients aged 2-6 years undergoing elective surgery under general anesthesia. This prospective double-blind study was conducted in 60 pediatric patients randomly allocated into the Atomized Group or the nasal drops group. Drug acceptance by a 4-point Medicine Acceptance Scale, Sedation, anxiolysis at the time of shifting, assessed by the Parental Separation Anxiety Scale (PSAS), and adverse events. Drug acceptance was superior in the atomized group compared to the nasal drops group (56.7% vs 3.3%; P < 0.001). The atomized group demonstrated statistically significantly higher sedation scores (2.53 ± 0.776 vs. 1.93 ± 0.583; P = 0.001) at 5 mins, indicating faster onset of sedation. PSAS scores were better in the atomized group (1.17 ± 0.592 vs. 1.53 ± 0.629; P = 0.024). Incidence of adverse events was comparable between both groups (P = 0.379), and no respiratory depression or hemodynamic instability was noted. Atomized intranasal midazolam via mucosal atomization device is superior to conventional nasal drops in achieving higher drug acceptance, faster sedation, and better parental separation anxiolysis in pediatric patients.

PMID 42553955
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多sumatriptan succinate